Technical development and manufacturing of vaccines in the context of worldwide regulatory requirements

Vaccine Insights 2024; 3(2), 71–75

DOI: 10.18609/vac.2024.014

Published: 17 April
Olga Rovira

Getting safe and effective vaccines to market quickly is essential in a pandemic situation, but this can be made more difficult by differing regional regulatory requirements. Casey Nevins, Assistant Editor, Vaccine Insights, speaks with Olga Rovira, Regulatory Affairs Senior Consultant in Vaccines and Managing Director, KONTIVAX SRL, about how worldwide regulatory requirements impact the technical development of vaccines, and potential solutions to this challenge.